EIZO Launches PX3150 Digital Pathology Monitor

The PX3150 is EIZO's first monitor built specifically for digital pathology. DCI 4K resolution, factory calibration, built-in sensor, and international regulatory clearance.

Hakusan, Japan, July 14, 2026 – EIZO Corporation (TSE: 6737) today announced the launch of the PX3150 – a 30.5-inch medical monitor with a resolution of 8 megapixels (4096 x 2160 pixels), offering a wider display area than standard 4K monitors (3840 x 2160), developed specifically for digital histopathology. Designed to support the growing adoption of digital pathology, the PX3150 addresses the need for reliable visual interpretation in diagnostic practice.

As digital pathology becomes an integral part of routine diagnostics, laboratories are managing growing case volumes alongside increasing diagnostic complexity. With histology workflows increasingly digitised through the scanning of tissue slides for microscopic evaluation, known as Whole Slide Imaging (WSI), pathologists now rely on digital images as the primary basis for interpretation. This shift makes consistency and reproducibility in visual presentation essential. The PX3150 is EIZO’s first dedicated pathology monitor, developed to support the precision and quality assurance required in this evolving medical field.

To ensure accurate color reproduction from first use, each PX3150 monitor is individually adjusted at EIZO’s factory. Colour gamut and gamma are precisely calibrated to accurately render the sRGB colour space, providing a reliable visual reference for the evaluation of digitised histopathology slides created through WSI.

Because a monitor’s display characteristics gradually change over time, regular recalibration is essential to maintain long-term consistency. The Integrated Front Sensor (IFS) built into the monitor’s bezel enables colour accuracy checks and calibration without the need for an external sensor. Using EIZO’s RadiCS quality control software’s scheduling function, routine quality checks can be run automatically during off-hours, such as overnight, allowing continuous quality management without interrupting daily clinical operations.

The PX3150 has obtained clearance from the U.S. Food and Drug Administration (FDA) for use as a Digital Pathology Display and complies with Class A requirements under the European In Vitro Diagnostic Regulation (IVDR), the EU regulatory framework for medical devices used in clinical laboratory testing. By meeting these international standards, the monitor provides a highly reliable display environment designed for pathology diagnostic applications.

As part of EIZO’s commitment to sustainability, the monitor’s housing is made of 70% recycled plastic. Its packaging uses moulded pulp made from recycled cardboard and newspaper instead of conventional recycled styrofoam or plastic, and cables are wrapped in paper instead of plastic bags. These efforts help reduce environmental impact and promote resource conservation.

As digital pathology continues to mature into routine clinical practice, the need for visual consistency becomes increasingly foundational. The PX3150 supports this transition by providing a stable visual basis for pathology interpretation in digital diagnostic environments.

Additional Features

Guaranteed luminance of 370 cd/m² for up to 10,000 hours over five years
EIZO’s proprietary Digital Uniformity Equaliser (DUE) technology for screen uniformity
DisplayPort™ x 2 and HDMI® inputs
USB Type-C® connectivity for video signal, USB data, and up to 94 W power delivery
LAN port built in for stable wired connection
Multi-monitor support with daisy chaining via USB Type-C

Availability

The PX3150 is now shipping. The date of availability may vary by country or region. Contact the nearest EIZO group company or distributor for details.

Product Information

EIZO PX3150

EIZO Sustainability Initiatives

Sustainability is a core principle that drives EIZO’s business strategy and operations. Dedicated to creating a positive impact on both society and the environment through responsible product design, efficient manufacturing processes, and innovative solutions, EIZO transparently discloses its environmental information in line with international initiatives such as the Task Force on Climate-related Financial Disclosures (TCFD) and the Task Force on Nature-related Financial Disclosures (TNFD).

As part of its sustainability efforts, EIZO is committed to achieving Net Zero emissions by 2040 through its Low-Carbon Transition Plan – Transition to Net Zero, focusing on addressing climate change, advancing circular economy principles, and reducing its environmental footprint throughout the entire value chain.

Learn more: https://www.eizoglobal.com/sustainability/

About EIZO

EIZO (TSE: 6737), which means image in Japanese, is a visual technology company that develops and manufactures high-end visual solutions to enrich people in their professional and personal lives. EIZO offers total imaging solutions with a range of monitors, software, video capture, processing, and distribution solutions, cameras, and advanced integrated technologies to meet the specialized needs of customers in business, creative fields, healthcare, air traffic control, maritime, security & surveillance, and more. Headquartered in Hakusan, Japan, EIZO has R&D and manufacturing facilities in Japan, China, Germany, and the United States, and representation in more than 130 countries.

EIZO and the EIZO logo are registered trademarks of EIZO Corporation in Japan and other countries. DisplayPort is a trademark of the Video Electronics Standards Association in the United States and other countries. The terms HDMI, HDMI High-Definition Multimedia Interface, HDMI trade dress and the HDMI Logos are trademarks or registered trademarks of HDMI Licensing Administrator, Inc. All other company names, product names, and logos are trademarks or registered trademarks of their respective owners.

Back to Spotlight